Literature DB >> 15536188

Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth.

Chunhui Xu1, Jianjie Jiang, Virginie Sottile, Jim McWhir, Jane Lebkowski, Melissa K Carpenter.   

Abstract

Human embryonic stem cells (hESCs) have the potential to generate multiple cell types and hold promise for future therapeutic applications. Although undifferentiated hESCs can proliferate indefinitely, hESC derivatives significantly downregulate telomerase and have limited replication potential. In this study we examine whether the replicative lifespan of hESC derivatives can be extended by ectopic expression of human telomerase reverse transcriptase (hTERT), the catalytic component of the telomerase complex. To this end, we have derived HEF1 cells, a fibroblast-like cell type, differentiated from hESCs. Infection of HEF1 cells with a retrovirus expressing hTERT extends their replicative capacity, resulting in immortal human HEF1-hTERT cells. HEF1-hTERT cells can be used to produce conditioned medium (CM) capable of supporting hESC growth under feeder-free conditions. Cultures maintained in HEF1-CM show characteristics similar to mouse embryonic fibroblast CM control cultures, including morphology, surface marker and transcription factor expression, telomerase activity, differentiation, and karyotypic stability. In addition, HEF1-hTERT cells have the capacity to differentiate into cells of the osteogenic lineage. These results suggest that immortalized cell lines can be generated from hESCs and that cells derived from hESCs can be used to support their own growth, creating a genotypically homogeneous system for the culture of hESCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15536188     DOI: 10.1634/stemcells.22-6-972

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  63 in total

1.  Human embryonic stem cell-derived mesenchymal stromal cells.

Authors:  Peiman Hematti
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  SNL fibroblast feeder layers support derivation and maintenance of human induced pluripotent stem cells.

Authors:  Chuanying Pan; Amy Hicks; Xuan Guan; Hong Chen; Colin E Bishop
Journal:  J Genet Genomics       Date:  2010-04       Impact factor: 4.275

3.  Human embryonic stem cells (hESCs) cultured under distinctive feeder-free culture conditions display global gene expression patterns similar to hESCs from feeder-dependent culture conditions.

Authors:  Tae-Min Yoon; Bomi Chang; Hyeung-Taek Kim; Joo-Hyun Jee; Dong-Wook Kim; Dong-Youn Hwang
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

4.  NF-κB activation impairs somatic cell reprogramming in ageing.

Authors:  Clara Soria-Valles; Fernando G Osorio; Ana Gutiérrez-Fernández; Alejandro De Los Angeles; Clara Bueno; Pablo Menéndez; José I Martín-Subero; George Q Daley; José M P Freije; Carlos López-Otín
Journal:  Nat Cell Biol       Date:  2015-07-27       Impact factor: 28.824

5.  Derivation of Man-1 and Man-2 research grade human embryonic stem cell lines.

Authors:  Maria V Camarasa; Robbie W Kerr; Sharon F Sneddon; Nicola Bates; Lisa Shaw; Rachel A Oldershaw; Fiona Small; Melissa A Baxter; Tristan R Mckay; Daniel R Brison; Susan J Kimber
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416

Review 6.  Human blastocyst culture and derivation of embryonic stem cell lines.

Authors:  Ariff Bongso; Shawna Tan
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 7.  Cardiac applications for human pluripotent stem cells.

Authors:  Yuji Shiba; Kip D Hauch; Michael A Laflamme
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Generation of mesenchymal stromal cells from HOXB4-expressing human embryonic stem cells.

Authors:  Yi-Ping Liu; Peiman Hematti
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

9.  Developmentally programmed 3' CpG island methylation confers tissue- and cell-type-specific transcriptional activation.

Authors:  Da-Hai Yu; Carol Ware; Robert A Waterland; Jiexin Zhang; Miao-Hsueh Chen; Manasi Gadkari; Govindarajan Kunde-Ramamoorthy; Lagina M Nosavanh; Lanlan Shen
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

10.  Small cytoskeleton-associated molecule, fibroblast growth factor receptor 1 oncogene partner 2/wound inducible transcript-3.0 (FGFR1OP2/wit3.0), facilitates fibroblast-driven wound closure.

Authors:  Audrey Lin; Akishige Hokugo; Jae Choi; Ichiro Nishimura
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.